Diapharm assists in EU registration of Chinese medicines

Diapharm (diapharm.com) has opened its representative office in Shanghai in July 2014 in reaction to a surging demand for pharmaceutical consultancy services in China. Diapharm helps pharmaceutical companies to obtain drug approval in Europe and assists them in quality assurance. “We will advise and assist Chinese companies as they make their way to Europe and also support European companies that purchase active ingredients or finished products from China and that may require assistance in auditing their suppliers,” Ralf Sibbing, general manager of Diapharm, explains.

Internationalisation of traditional Chinese medicine

Diapharm will assist Chinese pharmaceutical manufacturer Chengdu Huasun Group (www.huasungrp.com) with registering their sanchi-tongshu capsules in Europe. Zhou Yunjin, president of Chengdu Huasun Group, and Ralf Sibbing, managing director of Diapharm, signed a corresponding cooperation agreement in Chengdu on 30 June 2014. The objective is to achieve marketing authorisation for the medicinal product in several EU countries for the treatment of heart ailments. The product is based on active ingredients used in traditional Chinese medicine (TCM).

“Sanchi-tongshu capsules are also a pilot project for the modernisation and internationalisation of traditional Chinese medicine,” Zhou Menglin, vice director of Sichuan Science and Technology Department, emphasised at the signing. Huasun president Zhou Yunjin said: “With a share of more than 40 per cent, Europe is the largest market for traditional medicine.” The Huasun Group is one of the leading manufacturers of biopharmaceuticals and TCM products in China.

Background information: Diapharm
Diapharm is an international full-service provider to the healthcare industry. Founded in 1988, Diapharm supports pharmaceutical companies in all questions concerning regulatory affairs, medical & clinical development, quality management and business development. Its activities focus on the sectors of medicinal products, food supplements and dietetic food, medical devices and cosmetics. With over 100 employees in Germany, Austria, the United Kingdom and China, Diapharm is at the service of multinational companies as well as of new start-up companies and small to mid-sized businesses.

Background information: Chengdu Huasun Group Inc., Ltd.
Chengdu Huasun is a manufacturer of biopharmaceuticals as well as western and traditional Chinese medicine products. The company has its own research and development department, production, sales and after-sales service. Its product portfolio includes monoclonal antibodies, antibiotics, in-vitro diagnostics and TCM medicinal products. The company, which was established in 1996, is listed on the Shenzhen stock exchange (000790:Shenzhen). The company’s headquarters are in Chengdu, Sichuan, China.

Contact:
Diapharm
Press Office
Hafenweg 18-20
48155 Münster, Germany

Contact person:
Nicole Sibbing

phone: +49 (0)251 - 60935-517
nicole.sibbing@diapharm.com
www.diapharm.com

Diapharm GmbH & Co. KG
Shanghai Representative Office
Unit 701, No. 1258 Yuyuan Road
200050 Shanghai, P.R. China

Contact person:
Prudence Wu

phone: +86 (0)21 6142 2779
prudence.wu@diapharm.com
www.diapharm.com

Agency contact:
co-operate Wegener & Rieke GmbH
Zumsandestrasse 32
48155 Münster, Germany

Contact person:
Christian Rieke

phone: +49 (0)251 - 3222611
wort@co-operate.net
www.co-operate.net

This release was published on openPR.